HOME >> BIOLOGY >> NEWS
Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies

ed States Representative (N.Y.)

  • The Honorable Joseph L. Bruno, New York State Senate Majority Leader

  • The Honorable Elias Zerhouni, M.D., Director, National Institutes of Health

  • Bruce Alberts, Ph.D. President, National Academy of Sciences

  • Samuel Heffner Jr. '56, Chairman, Board of Trustees, Rensselaer Polytechnic Institute

  • Howard P. Isermann '42, Honorary Trustee, Rensselaer Polytechnic Institute

  • Robert E. Palazzo, Ph.D., Acting Director, Center for Biotechnology and Interdisciplinary Studies and Chair, Department of Biology, Rensselaer Polytechnic Institute

    "This extraordinary group of leaders in the sciences, engineering, business and government is rarely assembled in one place, and their participation is a testament to what the Rensselaer community has accomplished in a few short years," said Rensselaer President Shirley Ann Jackson. "By establishing the Center for Biotechnology and Interdisciplinary Studies, we have created a gathering place where scientists and engineers from various disciplines will explore at the intersection of the life sciences, with engineering and the physical and information sciences, thereby accelerating discovery and ultimately enhancing the quality of life for all people."

    Rensselaer's new center ranks among the world's most advanced research facilities focused on the application of engineering and the physical and information sciences to the life sciences. The Center for Biotechnology and Interdisciplinary Studies is a 218,000-square-foot, $100 million facility (including $80 million for construction). With its high-tech laboratories and expansive atrium, it provides a platform for collaboration among many diverse academic and research disciplines to enhance discovery and encourage innovation.

    The Center is designed to foster the multidisciplinary nature of biotechnology. It is organized around "constellations" of research Biocomputation and Bioin
    '"/>



  • Contact: Theresa Bourgeois
    bourgt@rpi.edu
    518-276-2840
    Rensselaer Polytechnic Institute
    2-Sep-2004


    Page: 1 2 3 4

    Related biology news :

    1. Rensselaer receives NIH grant to develop virtual surgery simulator
    2. New software developed at Rensselaer predicts promising ingredients for new drugs
    3. Rensselaer awarded $2.7 million NIH grant to improve drug development process
    4. National Institutes of Health grant to Rensselaer to further research on healing bone injuries
    5. Kimberly-Clark Worldwide donates intellectual property to Rensselaer
    6. Rensselaer effort to pull mussels at Lake George looks promising
    7. NASA Funds New Origin Of Life Center at Rensselaer Polytechnic Institute
    8. X marks the spot: Vector insertion is viral specific
    9. Despite darkness, nocturnal bees learn visual landmarks while foraging at night
    10. High Flux Isotope Reactor marks 400th cycle
    11. Study marks increased trends in infectious disease occurrences in our oceans

    Post Your Comments:
    (Date:11/21/2014)... , Nov. 20, 2014 Strict laws ... efficiency are piloting the North American and European automotive ... accidents growing, gesture recognition systems that are intuitive and ... mark in the industry. New analysis ... Gesture Recognition Market in Europe ...
    (Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
    (Date:11/18/2014)... , Nov. 17, 2014   ... and EMC collaborate to develop The Partners Data ... , The Partners Data Lake will allow researcher ... improve diagnostics, treatment and the lives of patients ... research and clinical activities across the Partners system, ...
    Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
    (Date:12/17/2014)... ROCKVILLE, Md. , Dec. 17, 2014 ... biopharmaceutical company dedicated to the acquisition, development and commercialization ... needs for the global market with a primary commercial ... that it has been granted a Type C meeting ... that the meeting will be held in February 2015.  ...
    (Date:12/15/2014)... Israel , Dec. 15, 2014  BrainStorm ... leading developer of adult stem cell technologies for neurodegenerative ... Ltd. was awarded a grant of approximately $1.1 million ... Chief Scientist (OCS).  This is the eighth year that ... the Office of the Chief Scientist, which is part ...
    (Date:12/15/2014)...  Ascendis Pharma A/S, a biotechnology company that ... unmet medical needs, today announced positive six-month interim ... to evaluate once-weekly TransCon Growth Hormone in children ... analysis consists of 25 patients, representing approximately 50% ... completing all six months of treatment. ...
    (Date:12/13/2014)... The DNA Microarray market market was ... expected to grow at a CAGR of 15.2% ... TOC of the DNA Microarray for an in-depth ... help of various tables and figures. , ... consists of instrument, consumables, and services, where the ...
    Breaking Biology Technology:CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 2DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 4
    Cached News: